title: Treatment of restless legs syndrome with subcutaneous apomorphine in a patient with short bowel syndrome.
authors.forename: T
authors.initials: T
authors.lastname: Tings
authors.forename: G
authors.initials: G
authors.lastname: Stiens
authors.forename: W
authors.initials: W
authors.lastname: Paulus
authors.forename: C
authors.initials: C
authors.lastname: Trenkwalder
authors.forename: S
authors.initials: S
authors.lastname: Happe
mesh_terms: D000328:Adult; D001058:Apomorphine / Q000008:administration & dosage* / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous / Q000379:methods; D012148:Restless Legs Syndrome / Q000188:drug therapy* / Q000209:etiology; D012778:Short Bowel Syndrome / Q000150:complications / Q000188:drug therapy*
chemical_list: D018491:Dopamine Agonists; D001058:Apomorphine
references.citation: Neuropsychobiology. 2003;48(2):82-6
references.pmid: 14504416
references.citation: Neurophysiol Clin. 2003 Sep;33(4):180-4
references.pmid: 14519546
references.citation: Acta Neurol Scand. 1999 Sep;100(3):163-7
references.pmid: 10478579
references.citation: Sleep Med. 2003 Mar;4(2):101-19
references.pmid: 14592341
references.citation: Mov Disord. 1995 Sep;10(5):634-42
references.pmid: 8552117
references.citation: CNS Drugs. 2004;18(1):27-36
references.pmid: 14731057
references.citation: J Clin Neurophysiol. 2001 Mar;18(2):128-47
references.pmid: 11435804
references.citation: Sleep Med. 2003 Mar;4(2):121-32
references.pmid: 14592342